Cargando…
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
OBJECTIVE: Topiramate is a repurposed first-line treatment for migraine prophylaxis. The aim of this systematic review and meta-analysis is to critically re-appraise the existing evidence supporting the efficacy and tolerability of topiramate. METHODS: A systematic search in MEDLINE, EMBASE, Cochran...
Autores principales: | Raffaelli, Bianca, García-Azorín, David, Boucherie, Deirdre M., Amin, Faisal Mohammad, Deligianni, Christina I., Gil-Gouveia, Raquel, Kirsh, Sarah, Lampl, Christian, Sacco, Simona, Uluduz, Derya, Versijpt, Jan, MaassenVanDenBrink, Antoinette, Zeraatkar, Dena, Sanchez-del-Rio, Margarita, Reuter, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563338/ https://www.ncbi.nlm.nih.gov/pubmed/37814223 http://dx.doi.org/10.1186/s10194-023-01671-5 |
Ejemplares similares
-
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023) -
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023) -
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022) -
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis
por: Lampl, Christian, et al.
Publicado: (2023) -
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)